Xeraya has successfully completed a substantial divestment of its stake in SBI in August 2014. Read more at this link.
The product portfolio of Small Bone Innovations Inc. (SBI), based in Morrisville, Pennsylvania, prior to its asset purchase by Stryker used to number more than 40 devices designed specifically for small bone and joint surgery, such as thumb, wrist, finger, elbow, foot and ankle.
The "star" among SBI's product portfolio was the Scandinavian Total Ankle Replacement System (the STAR Ankle), the only three-piece mobile bearing non-constrained, uncemented total ankle replacement that received the FDA’s pre-market approval to replace arthritic ankle joints. The FDA approved SBI's claim that the STAR Ankle has superior effectiveness compared to ankle fusion (the current gold standard) and has comparable safety results to ankle fusion in the clinical trials.
SBI now has a much reduced operating activity following the asset purchase of Stryker.
The founder and Executive Chairman, Dr. Anthony Viscogliosi, is responsible for the group’s worldwide strategy, business development, and financing. He also interfaces with strategic partners and orthopaedic community leaders. Dr. Viscogliosi has more than 27 years of experience in the orthopaedics industry as a serial entrepreneur, founder of several companies and banker.
Michael Simpson, President and Chief Executive Officer, is responsible for the worldwide sales, marketing, administration and operations. He has more than 16 years of senior management experience, including tenures at leading orthopaedic companies.
Dato’ Hans Brenner, the Executive Chairman of SBI APAC, is responsible for the business development and operational aspects of SBI APAC. He is the former President of B. Braun Asia Pacific, based in Penang, and has a broad background in the Malaysia and Asia Pacific medtech market. A resident of Malaysia for more than 15 years, he has acted as consultant to European and US companies setting up medtech operations in Asia.